Metabolism of methimazole by bovine liver microsomal flavine monooxygenase: Modulation by imipramine and chlorpromazine, comparison with sheep enzyme;Metimazolun siǧir karaciǧer mikrozomal flavin monooksijenaz tarafindan metabolizmasi: Imipramin ve klorpromazin ile deǧişimi, koyun enzimi ile karşilaştirilmasi

Turkish Journal of Biochemistry

Volumn 34, Issue 1, 2009, Pages 44-50

  Aktas, Deniz Fulya ^a,b   Can Demirdöǧen, Birsen ^a,c   Adali, Orhan ^a  

^a MIDDLE EAST TECHNICAL UNIVERSITY   (Turkey)

^b UNIVERSITY OF OKLAHOMA   (United States)

^c Gida Güvenliǧi ve Beslenme Araştirma Müdürlüǧü ^*  (Turkey)

Author keywords

Bovine; Flavin containing monooxygenase; Liver; Methimazole; Microsome

Indexed keywords

CHLORPROMAZINE; DIMETHYLANILINE MONOOXYGENASE; IMIPRAMINE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIAMAZOLE;

ARTICLE; CONTROLLED STUDY; COW; DRUG METABOLISM; DRUG OXIDATION; ENZYME ACTIVITY; LIVER MICROSOME; NONHUMAN; PH; SHEEP;

ANIMALIA; BOS; BOVINAE; OVIS ARIES;

EID: 65549093150     PISSN: None     EISSN: 1303829X     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Philpot RM, Smith BR. (1984) Role of cytochrome P-450 and related enzymes in the pulmonary metabolism of xenobiotics. Environ Health Perspect. 55:359-67.
2. Krueger SK, Williams DE. (2005) Mammalian flavin-containing monooxygenases: structure/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther. 106(3):357-87.
3. Cashman JR. (2000) Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism. Curr Drug Metab. 1(2):181-91.
4. Virkel G, Lifschitz A, Sallovitz J, Pis A, Lanusse C. (2004) Comparative hepatic and extrahepatic enantioselective sulfoxidation of albendazole and fenbendazole in sheep and cattle. Drug Metab Dispos. 32(5):536-44.
5. Hoffman SB, Yoder AR, Trepanier LA. (2002) Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats. J Vet Pharmacol Ther. 25(3):189-193.
6. Raiszadeh F, Solati M, Etemadi A, Azizi F. (2004) Serum paraoxonase activity before and after treatment of thyrotoxicosis Clin Endocrinol. 60(1):75-80.
7. Doganoc DZ, Grebenc S. (1998) Indirect determination of thiouracils in slaughter cattle by measuring the mass of the thyroid gland. Veterinarski Arhiv. 68:85-90.
8. Bergman U, Brittebo EB. (1999) Methimazole toxicity in rodents: Covalent binding in the olfactory mucosa and detection of glial fibrillary acidic protein in the olfactory bulb. Toxicol Appl Pharmacol. 155:190-200.
9. Avrupa Birliǧi Konseyi Direktifi 96/22. EC Council Directive 96/ 22, Official Journal of the European Community, 1996, No. L 125/3.
10. Hukkanen J, Dempsey D, Jacob P, Benowitz NL. (2005) Effect of pregnancy on a measure of FMO3 activity. Br J Clin Pharmacol. 60(2):224-226.
11. Sitar DS, Thornhill DP. (1973) Methimazole: absorption, metabolism and excretion in the albino rat. J Pharmacol Exp Ther. 184(2):432-9.
12. Poulsen LL. (1991) The multisubstrate FAD-containing monooxygenase. Chemistry and Biochemistry of Flavoenzymes (Derleyen: Miller F), vol. 2, s. 87-100, CRC Press, Boca Raton, FL:
13. Ziegler DM. (1988) Flavin-containing monooxygenases: catalytic mechanism and substrate specificities. Drug Metab Rev. 19:1-32.
14. Philpot RM, Biagini CP, Carver GT, Overby LH, Wyatt MK, Itagaki K. (1999) Expression and regulation of flavin-containing monooxygenases. Molecular and Applied Aspects of Oxidative Drug Metabolizing Enzymes (Derleyen: Arinc E ve diǧ.), s. 71-79, Plenum, New York.
15. Kruger SK, Yueh M-F, Martin SR, Pereira CB, Williams DE. (2001) Characterization of expressed full-length and truncated FMO2 from rhesus monkey. Drug Metab Dispos. 29:693-700.
16. Arinç E, Arslan S, Bozcaarmutlu A, Adali O. (2007) Effects of diabetes on rabbit kidney and lung CYP2E1 and CYP2B4 expression and drug metabolism and potentiation of carcinogenic activity of N-nitrosodimethylamine in kidney and lung. Food Chem Toxicol. 45(1):107-18.
17. Adali O, Arinç E. (1990) Electrophoretic, spectral, catalytic and immunochemical properties of highly purified cytochrome P-450 from sheep lung. Int J Biochem. 22(12):1433-44.
18. Arinç E, Philpot M. (1976) Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. J Biol Chem. 251(11):3213-20.
19. Bhamre S, Bhagwat SV, Shankar SK, Williams DE. (1993) Cerebral flavin-containing monooxygenase-mediated metabolism of antidepressants in brain: immunochemical properties and immunocytochemical localization. J Pharmacol Exp Ther. 267:555-559.
20. Tynes RE, Sabourin PJ, Hodgson E. (1985) Identification of distinct hepatic and pulmonary forms of microsomal flavin-containing monooxygenase in the mouse and rabbit. Biochem. Biophys. Res. Commun. 126:1069-1075.
21. Sabourin PJ, Smyser BP, Hodgson E. (1984) Purification of the flavin-containing monooxygenase from mouse and pig liver microsomes. Int J Biochem 16:713-720.
22. Williams DE, Ziegler DM, Nordin DJ, Hale SE. (1984) Rabbit lung flavin-containing monooxygenase is immunochemically and catalytically distinct from the liver enzyme. Biochem Biophys Res Commun. 125:116-122.
23. Tynes RE, Hodgson E. (1985) Catalytic activity and substrate specificity of the flavin-containing monooxygenase in microsomal systems: characterization of the hepatic, pulmonary and renal enzymes of the mouse, rabbit, and rat. Arch Biochem Biophys 240:77-93.
24. Schlenk D. (1998) Occurrence of flavin-containing monooxygenase in non-mammalian eukaryotic organisms. Comp Biochem Physiol C. 121:185-195.
25. Tynes RE, Philpot RM. (1987) Tissue and species-dependent expression of multiple forms of mammalian microsomal flavin containing monooxygenase. Mol Pharmacology. 31:569-574.
26. Falls JG, Cherrington NJ, Clements KM, Philpot RM, Levi PE, Rose RL, Hodgson E (1997). Molecular cloning, sequencing, and expression in Eschericia coli of mouse flavin-containing monooxygenase 3 (FMO3): comparison with the human isoform. Arch Biochem Biophys. 347:9-18.
27. Williams DE, Meyer HH, Dutchuk MS. (1989) Distinct pulmonary and hepatic forms of flavin-containing monooxygenase in sheep. Comp Biochem Physiol. 93B:465-470.
28. Kupfer D, Dehal SS. (1996) Tamoxifen metabolism by microsomal cytochrome P450 and Flavin-containing monooxygenase. Methods in Enzymology. (Derleyenler: Johnson EF, Waterman MR), vol. 272, s. 152-163, Academic Press, Inc. San Diego.
29. Bhamre S, Bhagwat SV, Shankar SK, Boyd MR, Ravindranath V. (1995) Flavin-containing monooxygenase mediated metabolism of psychoactive drugs by human brain microsomes. Brain Res. 672:276-280.
30. Cashman JR, Park SB, Berkman CE, Cashman LE. (1995) Role of hepatic flavin-containing monooxygenase 3 in drug and chemical metabolism in adult humans. Chem Biol Interact. 96(1):33-46.
31. Waiz MA, Ayezh R, Mitchell SC, Idle JR and Smith RL. (1987) Trimethylaminuria (fish-odoursyndrome); an inborn error of oxidative metabolism. Lancet 1:634-635.
32. Krause RJ, Ripp SL, Sausen PJ, Overby LH, Philpot RM and Elfarra AA. (1996) Characterization of the methionine S-oxidaze activity of rat liver and kidney for FMO3 being the major catalyst. Arch Biochem Biophys. 333:109-116.
33. Duescher RJ, Lawton MP, Philpot RM and Elfarra AA. (1994) Flavin-containing monooxygenase (FMO)-dependent metabolism of methionine and evidence for FMO3 being the major FMO involved in methionine sulfoxidation in rabbit liver and kidney microsomes. J Biol Chem. 269:17525-17530.
34. Cashman JR, Zhang J. (2002) Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation. Drug Metab Dispos. 30(10):1043-52.
35. Mitchell SC, Smith RL. (2001) Trimethylaminuria: the fish mal-odor syndrome. Drug Metab Dispos. 29:517-521.
36. Duringer JM, Buhler DR, Craig AM. (2004) Comparison of hepatic in vitro metabolism of the pyrrolizidine alkaloid senecionine in sheep and cattle. Am J Vet Res. 65(11):1563-72.
37. Virkel G, Lifschitz A, Soraci A, Sansinanea A, Lanusse C. (2000) Enantioselective liver microsomal sulphoxidation of albendazole in cattle: effect of nutritional status. Xenobiotica 30(4):381-93.
38. Huan JY, Miranda CL, Buhler DR, Cheeke PR. (1998) Species differences in the hepatic microsomal enzyme metabolism of the pyrrolizidine alkaloids. Toxicol Lett. 99(2):127-37.
39. Arinç E, Adali O. (1983) Solubilization and partial purification of two forms of cytochrome P-450 from trout liver microsomes. Comp Biochem Physiol. 76B:653-662.
40. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ. (1951) Protein measurement with Folin phenol reagent. J Biol Chem. 193:265-275.
41. Dixit A, Roche TE. (1984) Spectrophotometric assay of the flavin containing monooxygenase and changes in its activity in female mouse liver with nutritional and diurnal conditions. Arch Biochem Biophys. 233:50-63.
42. Can Demirdögen B, Adali O. (2005) Characterization and modulation by drugs of sheep liver microsomal flavin-monooxygenase activity. Cell Biochem Funct. 23:245-251.
43. Adali O, Carver GC, Philpot RM. (1998) Modulation of human flavin-containing monooxygenase 3 activity by tricyclic anti-depressants and other agents: importance of residue 428. Arch Biochem Biophys. 358:92-97.
44. Ziegler DM. (1993) Recent studies on the structure and function of multisubstrate flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol. 33:179-199.
45. Longin-Sauvageon C, Lattard V, Lilaz-Michel C, Buronfosse T, Beneoit E. (1998) Expression of two different FMOs in sheep liver. Drug Metab Dispos. 26 (3):284-287.
46. Ziegler DM, Poulsen LL, Duffel MW. (1980) Kinetic studies on mechanism and substrate specificity of the microsomal flavin-containing monooxygenase. Microsomes, Drug Oxidations and Chemical Carcinogenesis (Derleyenler: Coon MJ, Conney AH, Estabrook RW, Gelboin HV, Gillette JR, O'Brien PJ), vol. 2, s. 637-645, Academic Press, New York.
47. Narimatsu S, Yamamoto S, Kato R, Masubuchi Y, Horie T. (1999) Contribution of flavin containing monooxygenase and cytochrome P450 to imipramine N-oxidation in rat hepatic microsomes. Biol Pharm Bull. 22(6):567-71.
48. Guo Z, Raeissi S, White RB, Stevens JC. (1997) Orphenadrine and methimazole inhibit multiple cytochrome P450 enzymes in human liver microsomes. Drug Metab Dispos 25:390-393.
49. Rouer E, Rouet P, Delpech M, Leroux JP. (1988) Purification and comparison of liver microsomal flavin-containing monooxygenase from normal and streptozotocin-diabetic rats. Biochem Pharmacol. 37(18):3455-9.
50. Poulsen LL. (1981) Organic sulfur substrates for the microsomal flavin-containing monooxygenase. Reviews in Biochemical Toxicology (Derleyenler: Hodgson E, Bend JR, Philpot RM), vol. 3, s. 33-49, Elsevier North Holland, Inc.